In recent decades, science and technology have demonstrated profound advancements, bringing changes to society not seen since the industrial revolution. Average life expectancy has increased from 50 years of age in 1913 to 81.2 years of age in 2015, an increase of nearly 3 years per decade over the last 100 years.
| CONTEXT OF THE REVIEW
In recent decades, science and technology have demonstrated profound advancements, bringing changes to society not seen since the industrial revolution. Average life expectancy has increased from 50 years of age in 1913 to 81.2 years of age in 2015, an increase of nearly 3 years per decade over the last 100 years. 1 Many infectious diseases have become almost extinct. In spite of all this, medicine continues to face unparalleled health challenges. The last century was dominated by infectious agents and discoveries of antibiotics to combat them, and now, well into the present century, the focus of medicine is on the human body's interaction with the world around us. Longer lives, together with increased understanding of biological concepts, new biomaterials, advanced diagnostic tools, and therapeutic techniques, have brought about the possibility of studying and understanding health and disease differently. More than ever before, chronic, rather than communicable, diseases present the greatest global impact on health problems; and short-term remedies are being replaced with necessarily long-term management strategies. 2 Chronic diseases, including heart disease, cancer, and respiratory and metabolic diseases, are estimated to be responsible for 60% of deaths in the world. 3 The age of noncommunicable diseases has arrived. 4 Amongst noncommunicable diseases, the growing prevalence of obesity and its complications (including type 2 diabetes, cardiovascular disease, and nonalcoholic fatty liver disease) are increasingly dominating global ill health and healthcare costs.
At the center of many chronic diseases is inflammation, which is both multifactorial and complex in nature. While inflammation is associated with innate and adaptive immune responses functioning beneficially to protect and heal the body, if it becomes unbalanced it can be deleterious. It is now known that inflammation occurs in different forms (acute and chronic) and that it is driven by different mechanisms of induction, regulation, and resolution. Over the last half-century a shift in the types of inflammation present in humans has occurred-from acute inflammatory responses to injury and infection, to chronic inflammatory states often related to activation of the immune system (such as in rheumatoid arthritis), with the potential mechanisms underpinning the acute inflammatory responses becoming chronic in nature. 5 Research has demonstrated the role of a number of common risk factors for noncommunicable chronic diseases, such as genetics, tobacco use, stress, alcohol consumption, physical inactivity, adiposity, and diet, in modifying immune responses and ultimately increasing mortality and the financial burden to societies. [6] [7] [8] Periodontal diseases and obesity are also risk factors implicated in the onset and progression of chronic inflammation, and its consequences. Host responses are now understood to be governed not by one factor, but by multiple factors. They manifest differently in each individual, and are further determined by the interaction of factors within and around us, thus giving momentum to shifts in medical approaches toward personalized prediction that takes account of potential modifying factors. Health has become a game of risk played out by identifying possible negative factors and then implementing strategies to balance these negative factors with positive factors, in order to attain or maintain optimal health.
Medical models of chronic disease management suggest that new paradigms are needed to address the multiplicity of factors implicated in the pathogenesis of chronic diseases and to cope with the societal demands of the continually increasing incidence of these disorders.
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The shift to new systems to address the multifactorial nature of chronic diseases is strongly influenced by advances in science and technology that allow greater focus on predictive rather than reactive strategies.
Increased understanding of the potential modifying factors implicated in chronic disease onset or progression has highlighted interindividual variability, particularly of those factors influenced by lifestyle. 11 This knowledge has the potential to enhance opportunities to predict, prevent, and manage chronic conditions. The personalized medicine approach requires patients to play an active part in preventing or managing their own disease; it implies an altered role for the professional, who needs to establish, with the patient, a collaborative partnership that is focused on patient participation in the decision making related to therapeutic options. Furthermore, the professional, by acting as a facilitator, can enable and empower the patient to take a central DOI: 10.1111/prd.12239 It is within this context of overall health and chronic disease, with periodontitis and obesity both categorized as noncommunicable chronic inflammatory diseases, that this review investigates and discusses periodontal complications with obesity. Since 2010, periodontitis is cited to be the sixth most prevalent chronic condition globally; obesity and overweight have now become the norm, affecting 52% of the world's population. 14 The understanding of the pathophysiology of obesity has evolved over recent decades to recognize that chronic inflammation, rather than simply mechanical burden, drives its morbidity. 15 Their common coexistence and potential synergy for driving health risks suggest that it is time to consider overweight/obesity as a modifying factor in oral health, its assessment, and management. Cardiovascular disease, one of the main complications of obesity, is also understood to be driven by the chronic inflammation associated with periodontal diseases. This meta-review summarizes aspects of existing evidence related to the possible impact of obesity on periodontal conditions.
| BACKGROUND
The following sections provide background understanding of the chronic inflammatory diseases periodontitis (a destructive form of periodontal diseases) and overweight/obesity (relating to obesity as a neurochemical disease). A summary of the possible associations between the two diseases is presented as a foundation to permit detailed understanding of the evidence presented in this metareview, of the potential consequences of obesity on periodontitis and associated treatments and its relevance within the context of personalized medicine.
| Periodontal diseases

| Characteristics and prevalence
Periodontal diseases are chronic, multiinflammatory diseases of the periodontal tissues, propagated by an inflammatory response to bacterial plaque biofilm. 16, 17 Clinical manifestations of periodontal disease include gingival inflammation (which may lead to periodontal pocket formation as a result of loss of gingival attachment), gingival recession, alveolar bone loss, tooth mobility, and eventually (if the periodontal disease is untreated) tooth loss. 18, 19 In the general population, the prevalence of periodontitis is reported to be 20%-50%. 20 Most recent estimates in the USA, based upon Centers for Disease Control and Prevention updated case definitions, suggest 47% of the adult population suffer from the disease. 21 A recent systematic review considering the global burden of severe periodontitis between 1990 and 2010 estimates the prevalence of severe periodontitis at 11.2%, placing it as the 6th most prevalent global condition. 
| Etiology and pathogenesis
Despite robust evidence about the infectious nature of periodontitis, bacteria have proven to be essential, but not sufficient, to cause disease. 23 Historically, pathogenesis was attributed to specific organisms present in larger proportions, such as Porphyromonas gingivalis, Treponema denticola, and Tannerella forsythia, serving to trigger an inflammatory response. 24 More recent information emerging from metagenomic approaches highlight the polymicrobial nature of periodontal health and disease, with the latter attributed to a dysbiotic state of the periodontal microbiota. Keystone pathogens, including
P. gingivalis, could tip the balance of microbial homeostasis, leading
to an altered host-microbe interaction responsible for mediating distinctive inflammatory processes associated with the loss of periodontal tissues. 25 These local acute inflammatory processes aim initially at eliminating invading organisms. A lack of mechanisms of proresolution are deemed responsible for the transition to a chronic inflammatory state. 5, 24, 25 Toxic products associated with microbial shift, such as lipopolysaccharides within the gingival sulcus, may gain access to the gingival tissue and recruit a local inflammatory response characterized by neutrophils, lymphocytes, and macrophages. 26, 27 Local production of proinflammatory cytokines, such as interleukin-1beta, tumor necrosis factor alpha, and interleukin-6, in order to contain/clear the insult, is, however, associated with connective tissue destruction as a result of host matrix metalloproteinase activation. 26, 28, 29 A characteristic inflammatory infiltrate is observed in the periodontium; fibroblasts, junctional epithelial cells, osteoblasts/osteoclasts, macrophages, and polymorphonuclear leukocytes release proteinases that are involved in the defence against microbes. 29 At the same time, these host proteinases are capable of degrading all known extracellular components of connective tissue and epithelium, including components of both the external basal lamina (basement membrane at the connective tissue-junctional epithelium interface) and the internal basal lamina at the epithelium-tooth interface. These enzymes appear to have the potential to contribute to the lateral and apical proliferation of the junctional epithelium into the connective tissue, as well as to epithelial disintegration through degradation of the internal basal lamina and increases in epithelial permeability.
Regulation of proteinase activities involves activation of the active enzymes. 
| Risk assessment
Risk factors for a disease may be environmental, behavioral or biologic, which, if present, directly increase the probability of a disease occurring and, if absent or removed, reduce that probability. Evidence exists for the role of bacterial plaque, 36 cigarette smoking, 37, 38 diabetes mellitus, 39 and HIV infection 40 In 1998, the National Institutes of Health reported that "obesity is a complex multifactorial chronic disease", 55 followed by reference to obesity as a "chronic disease" by the World Health Organization in its report from the World Health Organization consultation on obesity in 1999. 54 Other bodies, including the American Medical Association, World Obesity Federation, and European Association for the Study of Obesity, all now recognize and classify obesity as a chronic disease. 56 While the mechanisms driving overweight and obesity are simply summarized as "an imbalance between energy intake and expenditure", the causes are more complex, involving gene-environment interactions for which the "complex feedback systems of both neural and endocrine signaling in response to intake of food", which evolved to respond to undernutrition, no longer protect the individual from overconsumption of food and subsequent weight gain. 53 Until recently, adipose tissue was believed to be inert tissue that stored fat as a fuel depot. It is now appreciated that adipose tissue is a highly active endocrine organ secreting chemicals that drive inflammation, and that fat can also be deposited outside adipose tissue, in sites such as the liver, thus driving localized inflammation. 57 Measuring body composition to derive estimates of the total amount of adipose tissue and its distribution is therefore essential for accurately phenotyping individuals and understanding the risks of overweight and obesity.
| Classification
The World Health Organization definition of obesity is based on the oldest and most common measure of body composition, body mass index. Body mass index was developed by Adolphe Quatelet in 1835 during his attempts to apply statistics to explain social phenomena. One of these was to classify people's weight relative to the perceived ideal weight for their height. 53 In the early 1900s, body mass index was used by the insurance industry to demonstrate shortened lifespan, resulting in defined thresholds. 58 The World Health Organization then adopted the measure, defining a classification system; the current cut-off points are shown in Table 1 .
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As more evidence emerges, the World Health Organization state that "health risks associated with increasing body mass index are continuous". 59 This has stimulated further breakdown of previous categories into subcategories to accommodate differing definitions of appropriate cut-off values for different ethnic backgrounds.
As other measures of body composition and shape have been incorporated, corresponding cut-off points have been proposed.
Recognition of the importance of central or visceral fat in mediating the health impact of overweight and obesity 60, 61 has resulted in the World Health Organization adding a threshold related to increased health risk for waist circumference (a proxy measure of central adiposity) at 94 cm for men and 80 cm for women. 59 This is a good predictor of visceral and even total body fat. 62 However, at high body mass index levels, it may be less accurate because of difficulties in obtaining an accurate measure. 63 It is generally recommended that more than one measure should be used, whenever possible, to assess body composition and fat distribution, with a selection of specific methods to be chosen based on their relevance to the health risk being assessed.
62,64
| Body composition and fat distribution
While body mass index is frequently used to define overweight and obesity, it is a poor proxy for body fat. 65 Body mass index has utility as a simple, objective, and reproducible estimate of fatness in population studies; however, particularly in modestly overweight individuals, body mass index may misclassify health risks. 64 As new technologies have become available offering more accurate measurements of regional fat distribution, the appropriateness of body mass index as a measure of visceral fat in ascertaining risk associated with adiposity has been challenged. 66, 67 Evidence suggests that body mass index has a very high correlation with waist circumference, waist: hip ratio, and computed tomography data regarding their association with clinical outcomes, such as diabetes incidence, and therefore body mass index remains the most commonly used measure of risk associated with central adiposity. 68, 69 In large epidemiological studies, body mass index remains predic- For example, the percentage of body fat increases with age for both men and women, and women generally have a higher percentage of body fat than men, regardless of age, from puberty onward. 73 More recently, attention has been focused on body fat distribution rather than solely on fat mass. Visceral (intra-abdominal) fat has been shown to be more highly associated with the metabolic syndrome than subcutaneous fat, with the suggested mechanism being linked to differences in adipokine secretion. 74 Figure 1 
| Health risks associated with obesity
Obesity has been said to "increase morbidity and mortality through its multiple effects on nearly every human system". 80 The World
Health Organization Global Observatory states that at least 2.8 million people worldwide die each year as a result of overweight or obesity, with mortality rates increasing with higher body mass index. 81 The disability-adjusted life year is a measure of overall disease burden, expressed as the number of years lost due to ill health.
It is estimated that globally, 35.8 million (2.3%) disability-adjusted life years are caused by overweight or obesity. 54 There is increasing research evidence demonstrating the association between obesity and increased risk for high blood pressure, cardiovascular disease, osteoarthritis, respiratory disorders, type 2 diabetes, reproductive dysfunction, gallbladder disease, and cancer.
In addition, an association of obesity with gastrointestinal, liver, urogenital, skin, and surgical site infections has been described. 80, 82, 83 To achieve optimal health, the median body mass index for an 89, 90 However, the recent rapid increase in the prevalence of obesity cannot be accounted for simply by genetic change, suggesting that environmental determinants are also important. 83 Environmental influences on overweight and obesity are primarily related to food intake and physical activity behaviors. In many countries where the population consumes westernized diets there is an overall abundance of palatable, calorie-dense food. In addition, aggressive and sophisticated food marketing in the mass media, supermarkets, and restaurants, and the large portions of food served outside the home, promote high calorie consumption. 91, 92 Many of our sociocultural traditions promote overeating and the preferential consumption of high-calorie foods. For many people, even when calorific intake is not above the recommended level, the number of calories expended in physical activity is insufficient to offset consumption. Many people are entrenched in sedentary daily routines consisting of sitting at work, sitting in traffic, and sitting in front of a television or a computer monitor for most of their waking hours. 83, 93 Research relating obesity to psychological disorders and emotional distress is based on community studies and clinical studies of patients seeking treatment. Several recent studies in general populations suggest a relationship between obesity and emotional problems. 94 Similarly, overweight people undergoing weight loss treatment may, in clinical settings, exhibit signs of emotional disturbance. In a review of dieting and depression, there was a high incidence of emotional illness symptoms in outpatients treated for obesity. 94 
| Pathogenesis
Adipose tissue, previously viewed as a passive energy store, is now referred to as an endocrine organ in itself. 80 As adipocytes become larger, they demonstrate altered activity with increased release of proinflammatory mediators and decreased release of antiinflammatory Hence, it is now known that adipose tissue is actively involved in the regulation of inflammation and immunity associated with the dysregulated or altered release of a variety of proinflammatory and anti-inflammatory factors (eg, leptin, adiponectin, cytokines, and chemokines). 80 Visceral fat (associated with central adiposity) has greater activity than peripheral fat cells regarding the production of endocrine secretions responsible for the effect of fat mass on immune function. 69, 98 The crucial role of adipose tissue in obesity-related systemic inflammation is the active production of hormones and cytokines, which acts as the link to many comorbidities of obesity. 99 known to play a role in insulin resistance. 75, 97 Table 2 lists the myriad of adipokine activity playing a role in the pathogenesis of adipose tissue, and the associated diseases. 97 There is evidence that some of the anti-or proinflammatory effects of adipokines are active in the innate immune response and that others stimulate an adaptive immune response. 
| Risk assessment
The World Health Organization has identified the importance of addressing common risk factors to reduce the prevalence of noncommunicable diseases, including obesity. 4, 52, 101 Linked to the multifactorial nature of overweight and obesity, identified risks include not only those at the individual level, but also those at a societal or environmental level. For health professionals, patient level modifiable risk factors are most relevant; however, these may be included with other, less modifiable, factors.
The most common risk factors for weight gain or obesity are tobacco cessation, consumption of foods high in saturated and trans fats, salt intake, sugar consumption (especially in sweetened drinks), sedentary lifestyle, as well as excessive alcohol consumption. 59 In F I G U R E 2 Cellular components of lean and obese adipose tissue. CCL2, C-C motif chemokine ligand 2; IL-1b, interleukin-1beta; IL-6, interleukin-6; TNF-a, tumor necrosis factor alpha addition, a number of medications are associated with weight gain.
These medications include some antidepressants, antiseizure medications, diabetes medications, antipsychotic medications, steroids, and beta-blockers. 102 A systematic review of weight gain following smoking cessation has shown that individuals who quit smoking will experience greater weight gain than nonsmokers for a minimum of 1 year. 103 Sucrose-containing drinks have been identified as a major dietary factor with a greater impact than many other types of food, partly because of the high number of calories in these products. Sugary drinks are easily and quickly consumed, and supply a large number of calories but little nutrition or sense of satiety. 104 Unhealthy diet and sedentary lifestyle are fundamental in assessing risk for overweight and obesity. Accordingly, the impact of these two factors in the etiology of obesity -energy in vs. energy out -is indisputable and they remain at the center of weight gain. However, awareness of a risk factor does not necessarily make it simple to modify.
Socioeconomic and environmental factors known to affect diet and activity levels have been identified as fundamental elements affecting the risk for overweight and obesity. Education levels and health awareness can influence food purchasing and cooking patterns. Lifestyle factors, such as watching television, eating out, working night shifts, and the distance between home and school or work, are just a few examples of confounding determinants of diet or physical activity. 55, 105, 106 Individuals with irregular and insufficient sleep patterns have been shown to be at a higher risk of weight gain. This is reported to be related to the link between hormone levels/neuroendocrine signaling and appetite/satiety; however, poor dietary habits associated with irregular sleep and work schedules have been implicated as a confounder in this association. 
| Therapy for obesity
Treatment of obesity aims to help the individual maintain a negative energy balance for a sufficiently long duration to utilize stored energy and thus lose weight, and then maintain a lower energy intake and/or increased energy expenditure for long-term maintenance of weight loss. 107 Treatment is problematic because there is clear evidence that physiological mechanisms try to maintain body T A B L E 2 Adipocytokine activity in adipose tissue pathogenesis
Adipocytokine
Inflammatory effect Effects on innate immunity Effects on adaptive immunity Associated diseases
Adiponectin Anti-inflammatory ↓Endothelial adhesion molecules 
Insulin resistance Experimentally induced hepatitis EAE and antigen-induced arthritis Experimentally induced colitis (mice) Asthma Cancer ↓, decrease; ↑, increase; CXCL, CXC-chemokine ligand; EAE, experimental autoimmune encephalomyelitis; ICAM, intercellular adhesion molecule; IFN-c, interferon-c; IL, interleukin; IL-1RA, IL-1 receptor antagonist; LPS, lipopolysaccharide; NF-kB, nuclear factor-kB; NK, natural killer; ROS, reactive oxygen species; Th-1, T-helper 1 cell; Th-2, T-helper 2 cell; TNF, tumor necrosis factor; VCAM, vascular cell adhesion molecule. Adapted from Tilg and Moschen. 95 weight and restore lost weight, and so-called lifestyle interventions (diet and exercise) result in weight loss of only 2%-3% which is maintained beyond 1-2 years. 108 More intensive interventions, such as those deployed in the Look Action For Health In Diabetes trial, or by using low (or very low) energy diets, can produce both greater initial weight loss and longer term weight-loss maintenance. 109 Pharmacotherapies have been developed that can, in conjunction with diet and lifestyle, produce greater and more sustained weight losses of 8%-10%. 110 However, the development of (laparoscopic) bariatric surgery has shown the greatest impact on weight loss, weight-loss maintenance, and improvement in complications caused by obesity, as well as opening research areas on mechanisms for weight loss, including gut hormones, microbiota, and bile acids. [111] [112] [113] It is also increasingly recognized that the weight loss achieved, and perhaps the mechanisms involved after bariatric surgery, have marked beneficial effects on adipose tissue and systemic inflammation. 
| Obesity and periodontal diseases
Obesity has been shown to modulate the host immune response, resulting in increased susceptibility to various infections and exaggerated host immune responses to them. 80 Adipose tissue (adipocytes) secretes several proinflammatory factors, also implicated in periodontitis, including cytokines (eg, interleukin-6) and chemokines, and can affect T-cell function. 80 Thirty years ago, experimental evidence sug- Personalized, preventive, and predictive medicine are dependent on robust research evidence to guide clinical assessment, diagnosis, and decision-making. Large volumes of published literature are available electronically to clinicians. However, the sheer mass of evidence can be overwhelming. Reviews serve to summarize bodies of evidence. Systematic reviews conducted according to a well-formulated question and protocol to minimize bias in the inclusion of primary studies facilitate the summary of numerous studies, thus allowing clinicians to keep abreast of current literature. 123 Furthermore, metaanalysis performed as part of systematic reviews combines results to provide an overall summary estimating the results of multiple studies. 124 In a situation in which multiple systematic reviews have been published, a meta-review proposes to summarize the content of these multiple systematic reviews, providing an optimal overview of existing evidence and gaps in the research findings. 125 Assessment of methodological quality is a key part of the process to assist readers in determining the validity and clinical applicability of the findings to their patients or setting. 126 Therefore, the aim of this review is to summarize research evidence to date pertaining to the possible periodontal complications with obesity, using a meta-review approach.
| META-REVIEW METHODS
This meta-review was designed and conducted based upon the Preferred Reporting Items for Systematic reviews and Meta-Analyses statement.
127,128
| Focused question
A focused question was developed using the population, exposure, comparison, outcome criteria 129 : "What is the association of periodontal diseases and/or periodontal complications and overweight/ obesity in children, adolescents, and adults?"
| Scope of the review
All systematic reviews were eligible for inclusion if they reported on research studies conducted in human subjects on the potential association or consequences of overweight/obesity and periodontal diseases in children, adolescents, or adults and were carried out according to systematic review methodology.
| Search and screening
The electronic search strategy was developed using Medical Subject Headings (MeSH) and freetext terms based on overweight/obesity and periodontal/periodontitis, then piloted to confirm its suitability to the focus of the review. In the electronic search, databases were searched to 31 October 2017 using a basic search strategy set a pri- Search results were combined in one database and duplicates were removed. Titles and abstracts (when available) of all reports identified through the search were screened by one reviewer (JES) for reviews appearing to meet the inclusion criteria. Full text articles were obtained for potentially relevant reviews, which were then further screened by two reviewers (JES and FD) to confirm their eligibility for inclusion. Narrative reviews or nonrelevant reviews were excluded.
| Risk of bias assessment and data abstraction
Assessment of the quality of included systematic reviews was performed according to A MeaSurement Tool to Assess systematic SUVAN ET AL.
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Reviews (AMSTAR). 123 Electronically generated evidence table templates were used for abstracting data from the full text articles (JS).
Evidence tables were quality checked for accuracy following data abstraction (FD).
| RESULTS
| Study selection
Electronic searches resulted in a total of 486 titles and abstracts, with 9 articles identified through checking of bibliographic lists, resulting in 342 being screened for eligibility following elimination of duplicates. Twenty-eight full text articles were screened for systematic reviews investigating the association of overweight/obesity and periodontal diseases. Following exclusion of narrative reviews or nonrelevant reviews, 14 full text systematic reviews were deemed eligible for inclusion in the meta-review. [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] Figure 4 depicts the Preferred Reporting Items for Systematic reviews and Meta-Analyses flow diagram summarizing the search and screening process.
Eleven of the 14 systematic reviews included were published between 2015 and 2017 with the remaining 3 being published between 2010 and 2014. Six reviews included only cross-sectional or longitudinal studies, while 8 reviews included only longitudinal or experimental studies. Two of the 14 reviews reported on children or adolescents only and 2 included adolescents with adult population samples. Table 3 provides an overview of the systematic reviews included, Figure 5 depicts the breakdown of study designs, and Figure 6 shows the proportion of studies providing evidence of an association between overweight/obesity and periodontal diseases. Table 4 summarizes the characteristics and results of the systematic reviews. Based on A MeaSurement Tool to Assess systematic Reviews (AMSTAR) for the bias assessment of systematic reviews, the majority of the included reviews were deemed to be of moderate-to-high quality ( Table 5 ).
The systematic reviews included focused on 4 main themes of association: overweight/obesity and periodontitis prevalence (some reporting extent and severity); incidence; response to periodontal therapy; and/or periodontal disease biomarkers. The 14 reviews contained some overlap of articles but only 2 included exactly the same articles. Overall, the 14 systematic reviews included a total of 133 unique study publications. Reviews published earlier included a larger number of observational studies, while more recent reviews included longitudinal and experimental studies.
| Overweight/obesity and periodontitis prevalence
Nine systematic reviews reported on the prevalence or extent and severity of periodontal complications in overweight or obese individuals. 131, 132, 134, 135, 136, 137, 138, 139, 143 Two of these reviews included studies solely of children and adolescents. 135, 136 Data from these 9 reviews show that obese individuals are more likely to have a form of periodontal disease than normal weight individuals, independent of age or gender. In addition, increasing levels of overweight through obesity are associated with more extensive and severe periodontitis.
| Overweight/obese and periodontitis incidence or progression
Four systematic reviews were identified that report on the incidence of periodontal diseases or progression in overweight/obese or cases of weight gain, with 2 including studies investigating children or adolescents. 134, 136, 141, 143 These summaries of longitudinal studies show that overweight/obesity or weight gain increases the risk of onset and/or progression of periodontal diseases.
| Overweight/obese and response to periodontal therapy
Six systematic reviews reported the potential effect of obesity on the clinical response to nonsurgical periodontal F I G U R E 3 Search strategy example for Ovid MEDLINE therapy. 131, 133, 134, 137, 140, 142 Two of these reviews included the same 5 studies. Overall, 5 reviews reported inconsistent evidence of differing clinical responses to nonsurgical periodontal therapy in obese individuals. One review reported evidence of obesity as a factor associated with a poorer response to nonsurgical periodontal therapy. All reviews reported the limited number of studies with small sample size and high levels of heterogeneity in design as restrictions to forming conclusive statements on the effect of obesity on healing following periodontal therapy.
| Overweight/obesity and biomarkers
Five systematic reviews reported on prevalence or change in biomarkers associated with inflammation, periodontitis, or obesity. 130, 131, 137, 140, 142 One review reported 2 studies demonstrating increased levels of tumor necrosis factor alpha and decreased levels of adiponectin in obese subjects, with a reduction of tumor necrosis factor alpha and increase in adiponectin following treatment. 142 However, it was noted that these results were not consistent across studies. The levels of C-reactive protein and proinflammatory cytokines tended to be higher in obese subjects than in nonobese subjects and showed a positive correlation to body mass index. Reduction of cytokine levels following periodontal treatment was reported in some studies but was inconsistent across studies. Each of the reviews reported inconsistency in results of the levels of serum cytokines in obese individuals and the potential effect of confounding factors.
| Overweight/obese and periodontal status in children/adolescents
Two reviews reported on studies of periodontal conditions, such as gingivitis and/or biomarkers of inflammation, in children or adolescents. 135, 136 These reviews reported poorer gingival health in obese subjects compared with nonobese subjects with an odds ratio of Interventions included:
• supra-gingival debridement
(1/15).
• nonsurgical periodontal therapy (8/15).
• nonsurgical therapy plus antibiotics (5/15).
• nonsurgical therapy plus surgical therapy (1/ • TNF-a: significant mean difference (P = .004).
• IL-6: no mean difference (P = .903).
• resistin: significantly higher resistin levels in obese subjects (P = .02).
• adiponectin: no mean difference (P = .23).
• leptin: no mean difference (P = .87).
• IL-8: no mean difference (P = .22).
• IL-1b: significant mean difference (P < .001) Aim: To assess the bidirectional association between tooth loss/edentulism and obesity Self-reported BMI (1 study).
BMI cut-off points combining overweight/obesity (2 studies).
BMI WHO Overweight separate from BMI WHO Obese (1 study).
Tooth loss cut-off points included:
• 1-5 missing teeth.
• 6-31 missing teeth.
• edentulous (1/4 studies).
• edentulism (1/4 studies).
• ≥1 missing teeth (2/4 studies)
Number of included studies: 16
(12 examining impact of edentulism on obesity and 4 considering impact of obesity on edentulism). Meta-analysis: 4 studies considering obesity as exposure.
Obese:
• OR = 1.49 (95% CI: 1.20-1.86) for any tooth loss.
• OR = Results of observational studies demonstrate a higher prevalence of periodontal disease in obese individuals than in nonobese individuals with a stronger association as obesity level increases. Some studies support the association between obesity and the development of periodontitis or weight gain and the development of periodontitis.
Studies reporting on response to therapy were inconsistent so the effect of obesity on response to periodontal treatment remains unclear
The association between obesity and periodontitis was consistent with a compelling pattern of increased risk of periodontitis in overweight or obese individuals. Although the underlying pathophysiological mechanism remains unclear, it has been pointed out that the development of insulin resistance as a consequence of a chronic inflammatory state and oxidative stress could be implicated in the association between obesity and periodontitis 95% CI, 95% confidence interval; ABL, alveolar bone loss; BMI, body mass index; BOP, bleeding on probing; CAL, clinical attachment level; CP, chronic periodontitis; CPI, Community Periodontal Index; CRP, C-reactive protein; GCF, gingival crevicular fluid; GI, gingival index; IFN-c, interferon-gamma; IL, interleukin; NSPT, nonsurgical periodontal therapy; OR, odds ratio; PI, plaque index; PD, periodontal disease; PPD, periodontal probing depth; RCTs, randomized controlled trials; RR, relative risk; TNF-a, tumor necrosis factor alpha; WC, waist circumference; WHO, World Health organization; WHR, waist/hip ratio. 
| Possible mechanisms
Published reports of the possible mechanisms or pathways connecting obesity and periodontal diseases continue to increase our understanding of the complexity of the association. An exaggerated host immune response was initially reported in an experimental model of periodontal bone loss. 116 Clinical evidence confirmed that obese individuals have an increased local inflammatory response 160 as well as an altered periodontal microflora. 161 As the host response to local bacterial challenge is a key factor in the pathogenesis of periodontitis, differences in the oral microbiome, together with an altered host response in obesity, have been investigated. Reports of the oral/periodontal microbiome composition in overweight and obese individuals remain few in number. A recent observational study reported obesity to be associated with increased proportions of periodontal pathogens, particularly in patients with obesity and chronic periodontitis, but also in obese individuals without periodontitis. 162 An investigation of obese individuals after bariatric surgery and an obese control group with or without periodontitis compared the oral and gastric presence of periodontal pathogens and Helicobacter pylori. Higher frequency of H. pylori was reported in both oral and stomach environments in patients who had undergone bariatric surgery compared with the obese control group (no surgery). 147 An alternative mechanism behind this association could be the altered insulin sensitivity state found in obese individuals. 163 Research suggests that reduced insulin sensitivity coupled with increased production and accumulation of advanced glycation endproducts at the gingival level in people with diabetes can result in greater periodontal tissue destruction. 39, 164 Researchers in Spain evaluated 110 obese and 102 lean individuals to determine the role of insulin resistance in the association between obesity and periodontitis. Individuals were divided into nonobese and obese groups, with and without insulin resistance, and were then assessed for inflammatory markers and periodontal status. In agreement with reports presented in the systematic reviews, the results showed that periodontitis was more prevalent and greater in extent and severity in obese subjects than in lean individuals, but was most extensive in obese subjects with insulin resistance. 145 Chronic periodontitis has been suggested as a distant source of inflammatory by-products affecting insulin sensitivity. 164 Tumor necrosis factor alpha is one of the cytokines secreted by visceral adipose tissue in particular, and is implicated in mediation of endotoxin-induced injury in periodontal tissue. 165 The concentrations of tumor necrosis factor alpha have been reported to be higher in patients with periodontitis compared with periodontally healthy patients, and have been shown to be reduced following periodontal therapy. 161 In the previously mentioned study investigating the role of insulin resistance, the levels of tumor necrosis factor alpha and high sensitivity C-reactive protein were higher in all obese subjects than in nonobese subjects. 145 Higher levels of tumor necrosis factor alpha in gingival crevicular fluid has been shown to be associated with a body mass index of ≥40. 75 An association of tumor necrosis factor alpha in gingival crevicular fluid with body mass index has also been demonstrated in obese subjects without periodontitis. It is suggested that tumor necrosis factor alpha found in gingival crevicular fluid of obese subjects may be secreted from the adipose tissue. 164 Production of reactive oxygen species resulting in oxidative stress has been investigated as a pathway that may be linked to insulin sensitivity and contributing to a proinflammatory state in obese individuals. An early study showed secretion of reactive oxygen species to be upregulated in adipose tissue and the liver of mice on a high fat diet. 166 Oxidative stress has also been implicated in severe periodontitis with the suggestion of obesity playing a contributing role. 167, 168 This notion is supported by a study that compared oxidative stress in nonobese and obese subjects who were periodontally healthy or had gingivitis or periodontitis. They found oxidative stress to be higher in the obese plus chronic periodontitis group compared with the nonobese plus chronic periodontitis group; higher in the obese plus gingivitis group compared with the nonobese plus gingivitis group; and higher in the periodontally healthy group compared with the periodontally healthy nonobese group. 169 In a similar study design (4 groups), Suresh et al 170 also reported more oxidative stress in obese individuals with periodontitis compared with periodontally healthy individuals with obesity.
Leptin, also secreted from adipose tissue, plays a role in immune system function and it is suggested that it plays a role in the pathogenesis of chronic inflammation, with the elevated levels of leptin in obesity believed to contribute to the low-grade inflammation. . 180 It is possible that microRNAs modified in obesity may affect the inflammatory gene targets that predispose to periodontitis. 181 The increase in adipokines released from adipocytes triggers macrophage infiltration and the release of cytokines such as interleukin-1beta, interleukin-6, and tumor necrosis factor alpha, leading to insulin resistance and the induction of more inflammation. This demands an increasingly interactive approach to patient care that is focused on healthy lifestyle strategies to address modifiable risk factors supplemented by personalized choices of professionally rendered therapies.
In the context of overweight and obesity, the first step might be for every dental professional to incorporate recordings of height and weight (with subsequent calculation of body mass index) into daily practice as a part of risk assessment. Additionally, assessing fat distribution by measuring waist circumference could add to risk stratification. Both measures could increase awareness of overweight and obesity with patients. Similarly to the issue of self-awareness and reporting of smoking, people tend to underestimate their weight but tend to overestimate their height, resulting in a misconception of their body mass index. 184, 185 As a consequence of not knowing their body mass index category, many people may not associate the health risks that they hear are related to a high body mass index as something that is relevant for them.
Likewise, it is proposed that practitioners caring for patients with obesity should be aware of the possible increased risk of periodontitis in their obese patients, and of its potential to add to the already obesity-related elevation in cardiovascular risk. While obesity management may not yet be proven to reduce this, periodontal treatment certainly has been, and should therefore be a mandatory part of comprehensive care, with possibly even referral for periodontal assessment, as has already been proposed for professionals treating patients with diabetes. 186 The action plan proposes a multifaceted collaborative approach to involve health professionals, industry, governments, and the public in reducing the common modifiable risk factors for noncommunicable diseases. 187 It is suggested that dental professionals could play a role in this collaborative approach.
| IMPLICATIONS FOR RESEARCH
The results of this meta-review suggest that further studies are required to replicate the current findings in specific population samples in order to explore differences according 
| CONCLUSION S
In conclusion, the results presented in this meta-review support the notion of obesity as a factor contributing to periodontal complications. Specifically, the included systematic reviews provide evidence of an association between overweight/obesity and the prevalence, extent, and severity of periodontal diseases, and treatment response in all age groups. In the context of personalized and predictive medical models that suggest the importance of risk assessment, these findings suggest that dental professionals should periodontal complications in overweight/obese patients, and should be prepared to refer patients to dental professionals for further care. Additional prospective studies, to further quantify the magnitude of this association and understand the exact mechanisms, together with studies of periodontal interventions in obese individuals, are merited.
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